Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RWJ-333369 (Carisbamate) for Migraine Prophylaxis
NCT00109083Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Mar 2002
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carisbamate in migraine, sponsored by SK Life Science, Inc.. Started Mar 2002; status: completed.
02
Drugs
carisbamate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00109083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109083.